Development of a potent, broadly protective vaccine against

In a recent study published in the journal npj Vaccines, researchers in China designed, produced, and evaluated the neutralization efficacy of a recombinant coronavirus disease 2019 (COVID-19) vaccine containing four hot-spot substitution mutations based on a prefusion-stabilized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) trimer.

Related Keywords

China , Syria , Wuhan , Hubei , Switzerland , Syrian , Swiss , , World Health Organization , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Image Credit , Golden Syrian , Automation Industry Focus , Golder Syrian , Coronavirus Disease Covid 19 , Ars Cov 2 , Vaccine , Antibodies , Ntibody , Ntigen , Essay , Flood , Coronavirus , Covid 19 , Pg , Ytokine , Efficacy , Nzyme , Immunity , Utation , Micron , Caroline , Protein , Eceptor , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Spike Protein , Yndrome ,